LONDON--(BUSINESS WIRE)--Technavio has been monitoring the global electric arc furnaces market and the market is poised to grow by USD 470 million during 2019-2023 at a CAGR of nearly 11% during the ...

PEAK-1, a Phase 3 study evaluating casdatifan + cabozantinib in immunotherapy (IO)-experienced ccRCC, and eVOLVE-RCC02, a Phase 1b/3 study sponsored by AstraZeneca evaluating casdatifan + volrustomig ...

At least two additional data presentations for casdatifan are expected in 2026: updated data for casdatifan plus cabozantinib and initial data in early-line kidney cancer In addition to the ongoing ...

HAYWARD, Calif.--(BUSINESS WIRE)-- Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for ...

Well, here we are, another year, another conference. So welcome to the leadership team for Arcus, very familiar faces. Terry Rosen, the CEO; Jen Jarrett COO; Thanks. Hi, Pia and I'm Yigal Nochomovitz, ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...